Skip to main content

PACS Group, Inc.

corporate_fare Company Profile

PACS Group, Inc.

PACS·NYSE·Industrial Applications And Services·CIK 0002001184

PACS Group, Inc. is a post-acute healthcare company primarily focused on providing skilled nursing care. Founded in 2013, it is one of the largest skilled nursing providers in the United States by number of facilities. The company operates 321 post-acute care facilities across 17 states, serving over 31,700 patients daily. In addition to skilled nursing, PACS Group, Inc. also offers senior care, assisted living, and independent living options in some of its communities. The company's growth has largely stemmed from acquiring underperforming long-term custodial care skilled nursing facilities and converting them into higher acuity, high value-add short-term transitional care skilled nursing facilities. Its operating model is locally led and centrally supported, empowering local leaders at each facility to operate autonomously. PACS Group, Inc. provides its independently operated facilities with technology, support, and back-office services, allowing local leadership to concentrate on patient care. Skilled nursing facilities are central to the post-acute care ecosystem, offering cost-efficient facility-based care for patients discharged from hospitals who still require 24-hour in-patient services, including both long-term custodial care and short-term transitional care.

PACS Group, Inc. (NYSE:PACS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for PACS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-01, rated 8/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for PACS spans 8-K, 10-Q, 144, 4.

Recent high-impact activity:

  • PACS Group Adds 32 Florida Skilled Nursing Facilities in New Deal
  • PACS Group Lifts 2026 EBITDA Outlook by $35M at Midpoint
  • PACS Group Lifts 2026 EBITDA Guidance by $35M at the Midpoint Following a Strong Q2 Beat
  • PACS Group Q2 Revenue Reaches $1.43B, Net Income Climbs 50%, Yet Material Weaknesses and Federal Probes Persist
  • Officer and Director Mark Hancock files intent to sell $6.44 million in PACS Group stock

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.29B
Net Income
$191.54M
Diluted EPS
$1.22
Op. Cash Flow
$404.22M
Operating Income
$309.6M
Cash & Equivalents
$197.02M
Total Debt
$249.27M
Debt / Equity
0.26×
Net Margin
3.6%
Shares Outstanding
156.62M sh
Source: 10-K · filed 2026-02-27 · accession 0002001184-26-000005
Browse all tickers starting with P →
$43.76 -0.79% today
52-week range · as of 2026-08-04 $7.5 – $48
Market cap
$7.05B
Volume
760K (1.0× avg)
3-mo avg 763K
Live data · 2026-09-15 09:31 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed PACS - Latest Insights

PACS
Sep 01, 2026, 4:16 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $42.14
Real-time Price: $43.76 info
Change: +$1.62 (+4%) info
Market Cap: $7.054B info
PACS
Aug 04, 2026, 4:45 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $45.15
Real-time Price: $43.76 info
Change: -$1.39 (-3%) info
Market Cap: $7.054B info
PACS
Aug 04, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $44.62
Real-time Price: $43.76 info
Change: -$0.8606 (-2%) info
Market Cap: $7.054B info
PACS
Aug 04, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $44.62
Real-time Price: $43.76 info
Change: -$0.8606 (-2%) info
Market Cap: $7.054B info
PACS
Jul 06, 2026, 4:51 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $45.00
Real-time Price: $43.76 info
Change: -$1.24 (-3%) info
Market Cap: $7.054B info
PACS
Jun 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $39.94
Real-time Price: $43.76 info
Change: +$3.82 (+10%) info
Market Cap: $7.054B info
PACS
Jun 26, 2026, 2:22 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $41.18
Real-time Price: $43.76 info
Change: +$2.58 (+6%) info
Market Cap: $7.054B info
PACS
May 11, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $37.98
Real-time Price: $43.76 info
Change: +$5.78 (+15%) info
Market Cap: $7.054B info
PACS
May 11, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $37.98
Real-time Price: $43.76 info
Change: +$5.78 (+15%) info
Market Cap: $7.054B info
PACS
May 01, 2026, 2:16 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $33.00
Real-time Price: $43.76 info
Change: +$10.76 (+33%) info
Market Cap: $7.054B info
PACS
Apr 27, 2026, 4:36 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.27
Real-time Price: $43.76 info
Change: +$8.49 (+24%) info
Market Cap: $7.054B info
PACS
Mar 17, 2026, 6:32 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $35.70
Real-time Price: $43.76 info
Change: +$8.06 (+23%) info
Market Cap: $7.054B info
PACS
Mar 05, 2026, 4:32 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.57
Real-time Price: $43.76 info
Change: +$8.19 (+23%) info
Market Cap: $7.054B info
PACS
Feb 26, 2026, 9:10 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $41.88
Real-time Price: $43.76 info
Change: +$1.88 (+4%) info
Market Cap: $7.054B info
PACS
Feb 26, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $41.67
Real-time Price: $43.76 info
Change: +$2.09 (+5%) info
Market Cap: $7.054B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets